| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
NEUROSCIENCE |
Departments of
1 Biology
2 Biochemistry and Molecular Biology, Huck Institutes of Life Sciences, The Pennsylvania State University, University Park, PA 16802, USA
3 Department of Physiology, Shanxi Medical University, Taiyuan, Shanxi 030001, P. R. China
 |
Abstract |
|---|
 Top Abstract IntroductionMethodsResultsDiscussionReferences |
|---|
2 subunit-containing postsynaptic GABAA receptors. In contrast, tonic GABA currents, assessed either by a GABAA receptor antagonist bicuculline or a selective extrasynaptic GABAA receptor agonist THIP, were significantly reduced following epileptogenic stimulation. These results reveal a novel form of neural plasticity, that epileptogenic stimulation can selectively downregulate extrasynaptic GABAA receptors while leaving synaptic GABAA receptors unchanged. Thus, in addition to synaptic alteration of GABAergic transmission, regulation of tonic inhibition may also play an important role during epileptogenesis.
(Received 15 May 2006;
accepted after revision 20 September 2006;
first published online 21 September 2006)
Corresponding author G. Chen: Department of Biology, 201 Life Sciences Building, Huck Institutes of Life Sciences, The Pennsylvania State University, University Park, PA 16802, USA. Email: gongchen{at}psu.edu
|
Introduction |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
GABAA receptors are abundant at both synaptic and extrasynaptic sites. Synaptic GABAA receptors have low affinity for GABA and primarily mediate fast inhibitory transmission also known as phasic inhibition, whereas extrasynaptic GABAA receptors exhibit high affinity for GABA and mediate tonic inhibition (Mody & Pearce, 2004; Semyanov et al. 2004). Comparing to the well-characterized synaptic GABAergic inhibition, much less is understood for the tonic inhibition. Gene knockout studies reveal that deleting extrasynaptic GABAA receptors that contain an 
5, 6, or 
subunit results in a significant reduction of tonic but not phasic GABA currents (Brickley et al. 2001; Stell et al. 2003; Caraiscos et al. 2004). Blocking extrasynaptic GABAA receptor-mediated tonic inhibition significantly enhanced neuronal excitability, suggesting an important function of tonic inhibition in the information process in the brain (Hamann et al. 2002; Semyanov et al. 2003, 2004; Mody, 2005).
It is known that alteration of synaptic GABAergic inhibition plays a critical role during epileptogenesis (Sperk et al. 2004), but whether regulation of tonic inhibition plays any role is not clear (Richerson, 2004). Houser & Esclapez (2003) first reported that immunostaining of extrasynaptic 5 subunit-containing GABAA receptors was significantly reduced in hippocampus of the pilocarpine-induced rat model of TLE. Expression of subunit-containing extrasynaptic GABAA receptors in the dentate gyrus was similarly reduced in the same model (Peng et al. 2004).
We have recently established a novel epilepsy model in which cyclothiazide (CTZ) induces robust epileptiform activity in hippocampal neurons both in vitro and in vivo (Qi et al. 2006). Here we have further analysed changes in GABAA receptor function associated with epileptiform activity induced by chronic CTZ treatment, and compared them to changes in the well-established chronic kainic acid (KA) model of epilepsy. Irrespective of the stimulation protocol, epileptiform activity of cultured hippocampal neurons was associated with a significant reduction of the whole-cell GABA currents and the frequency of mIPSCs. However, the amplitude of mIPSCs mediated by synaptic GABAA receptors was not altered. Immunocytochemical analysis confirmed that the postsynaptic GABAA receptor puncta and size remained largely unaffected by epileptogenic stimulation. Interestingly, tonic GABA currents revealed by a GABAA receptor antagonist or selective agonist for extrasynaptic GABAA receptors were markedly reduced following epileptogenic stimulation. Therefore, extrasynaptic GABAA receptors exhibit a heightened functional vulnerability to epileptogenic stimulation, and suggest that downregulation of tonic GABA currents may contribute to epileptogenesis.
|
Methods |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
Primary hippocampal cultures were prepared as previously described (Deng & Chen, 2003; Chen et al. 2004; Qi et al. 2006). In brief, brains from newborn Sprague-Dawley rats were removed and placed in ice-cold modified Hank's balanced salt solution (HBSS). The hippocampal CA1–CA3 region was dissected, cut into 
1 mm3 cubes and incubated with 0.05% trypsin–EDTA in HBSS for 30 min at 37°C. After trypsin treatment, tissue blocks were triturated with HBSS with 10% horse serum, and dissociated cells were plated onto a monolayer of astrocytes. The culture medium contained 500 ml MEM (Gibco), 5% fetal bovine serum (Hyclone, Logan, Utah, USA), 10 ml B27 (Invitrogen, Carlsbad, California, USA), 100 mg NaHCO3, 20 mM
D-glucose, 0.5 mM
L-glutamine, and 25 u ml–1 penicillin/streptomycin. Culture medium containing 4 µM AraC to stop glial proliferation was replaced three times in the first week and cultures were maintained in a 5% CO2 incubator for 2–3 weeks. The neonatal pups (P0–P1) were decapitated and the adult rats were killed with CO2 according to the animal protocols approved by IACUC committee in Pennsylvania State University and conforming with the federal guidelines.
Whole-cell patch-clamp recordings
Whole-cell recordings of action potentials, mIPSCs and GABA application-induced currents were made in current- or voltage-clamp mode using a MultiClamp 700A amplifier (Molecular Devices Corporation, Sunnyvale, CA, USA). Patch pipettes were pulled from borosilicate glass and fire polished (2–4 M
). The recording chamber was continuously perfused with a bath solution consisting of (mM): 128 NaCl, 30 glucose, 25 Hepes, 5 KCl, 2 CaCl2, 1 MgCl2, pH 7.3 adjusted with NaOH. The pipette solution for recording action potentials contained (mM): 125 K-gluconate, 10 KCl, 2 EGTA, 10 Hepes, 10 Tris-phosphocreatine, 4 MgATP, 0.5 Na2GTP, pH 7.3 adjusted with KOH. For mIPSCs, tonic GABA currents and GABA-induced whole-cell currents, patch pipettes were filled with (mM): 135 KCl, 10 Tris-phosphocreatine, 2 EGTA, 10 Hepes, 4 MgATP, 0.5 Na2GTP, pH 7.3 adjusted with KOH. The series resistance was typically 10–20 M and partially compensated by 30–50%. The membrane potential was held around –70 mV in both voltage-clamp and curren-clamp recordings. Data were acquired using pClamp 9 software (Molecular Devices Corporation, Sunnyvale, CA, USA), sampled at 2–10 kHz, and filtered at 1 kHz. Offline analysis was done with Clampfit 9 software. Miniature events were analysed using MiniAnalysis software (Synaptosoft). All data were expressed as mean ±
S.E.M. and Student's t test was used for statistical analysis.
Epileptiform activity is defined by at least five consecutive action potentials overlaying a large depolarization shift of minimally 10 mV in amplitude and 
300 ms in duration. The criteria for quantifying the percentage of neurons showing epileptiform activity is at least four recurrent epileptiform bursts occurring in a 30 min recording period. Pyramidal shape neurons were selected for recordings. For each neuron recorded after KA or CTZ treatment, epileptiform discharges were first verified under current clamp before recording mIPSCs and GABA-evoked currents under voltage clamp.
Immunofluorescent staining and quantification
Immunofluorescent staining of cultured neurons was performed as described (Alldred et al. 2005). Briefly, neurons were washed with PBS, fixed in 4% paraformaldehyde for 12 min and permeabilized for 5 min with 0.2% Triton X-100 in PBS containing 10% donkey serum. The primary antibodies mAb SV2 (1: 2000) and GAD65 (1: 75, Developmental Studies Hybridoma Bank, University of Iowa, Iowa City, IA, USA) were used to label total and GABAergic nerve terminals, respectively, and developed with CY3-conjugated donkey antimouse secondary antibody (Jackson ImmunoResearch, West Grove, PA, USA; 1: 500). Postsynaptic GABAA receptors were stained with guinea-pig anti-2 subunits (1: 1500) (Fritschy & Mohler, 1995) and developed with Alexa Fluor 488-conjugated goat anti-guinea-pig secondary antibodies (1: 1000 Molecular Probes, Eugene, OR, USA). Fluorescence images were captured with an ORCA-100 camera on a Zeiss Axiophot 2 microscope equipped with a x40, 1.3 NA objective and controlled by Openlab software (Improvision Inc., Lexington, MA, USA). Quantification of postsynaptic GABAA receptors was performed as described (Alldred et al. 2005). For quantification of presynaptic bouton numbers, immunoreactive puncta for glutamic acid decarboxylase (GAD) or the general presynaptic marker SV2 along 100 µm dendrite per neuron were analysed using SimplePCI software (Compix Inc., Cranberry, PA, USA), as previously described (Chen et al. 2003). Synaptic density determined by the number of puncta per 100 µm dendrite was compared between different experimental groups.
Drugs
Cyclothiazide, kainic acid, bicuculline, 4,5,6,7-tetrahydroisoxazolo[5,4-c]-pyridin-3-ol (THIP), D(–)-2-amino-5-phosphonopentanoic acid (AP5), and 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX) were purchased from Tocris (Bristol, UK). TTX and GABA were obtained from Sigma. All of the drugs were freshly diluted in bath solution to final concentrations before experiments. Bath application of drugs was rapidly delivered through a micropipette (400–500 µm tip) positioned about 1000 µm away from recorded neurons at a 45 deg angle. The micropipette was connected to a Warner (Hamden, CT, USA) VC-6 drug delivery system.
|
Results |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
CTZ increases neuronal excitability by synergistically enhancing the excitatory glutamate response and reducing the inhibitory GABA response (Diamond & Jahr, 1995; Bellingham & Walmsley, 1999; Ishikawa & Takahashi, 2001; Deng & Chen, 2003; Qi et al. 2006). Hippocampal CA1–CA3 cultures (>12 days in vitro) were treated with CTZ (5 µM) for 48 h to induce epileptiform activity (Qi et al. 2006). After removal of CTZ, whole-cell patch-clamp recordings revealed periodic bursting activity with large depolarization shift, a hallmark of epileptiform activity (Fig. 1B, n = 21). In contrast, control neurons typically exhibited low-frequency firing of action potentials as well as spontaneous postsynaptic potentials (Fig. 1A, n = 18). Since chronic CTZ pretreatment (5 µM, 48 h) reliably induces epileptiform activity in the majority of hippocampal neurons (Qi et al. 2006), this protocol was used throughout this study to investigate the chronic effects of epileptogenic stimulation on the GABAergic transmission system.
|
Previous studies suggest that alteration of GABAergic neurotransmission may contribute to epileptogenesis (Gibbs et al. 1997a; Kobayashi & Buckmaster, 2003; Leroy et al. 2004; Macdonald et al. 2004; Dzhala et al. 2005; Mody, 2005). We first examined possible changes in GABAergic synaptic transmission by investigating the frequency and amplitude of miniature inhibitory postsynaptic currents (mIPSCs) after CTZ induction of epileptiform activity. The mIPSCs were recorded in the presence of the action potential blocker TTX (0.5 µM) and the AMPA/kainate receptor antagonist CNQX (20 µM). CTZ-pretreated neurons recorded under current-clamp condition were confirmed to show epileptiform activity before recording mIPSCs. Miniature IPSC traces recorded from CTZ-pretreated neurons showed a clear reduction in the mIPSC frequency compared to untreated controls (Fig. 2A and B). The average mIPSC frequency after CTZ pretreatment was 0.59 ± 0.05 Hz (n = 26), which was significantly lower than the control frequency of 1.33 ± 0.09 Hz (n = 28, P < 0.001; Student's t test) (Fig. 2C). In contrast to the frequency changes, the mIPSC amplitude of CTZ-pretreated neurons (20.0 ± 1.6 pA, n = 26) was the same as that of controls (22.3 ± 1.7 pA, n = 28; P > 0.3) (Fig. 2D). The unaltered mIPSC amplitude suggests that the postsynaptic GABAA receptors are relatively intact, while the significant change of the mIPSC frequency indicates presynaptic alterations in CTZ-pretreated neurons.
|
The significant decrease of mIPSC frequency after CTZ pretreatment may be caused by a reduction of the number of GABAergic synapses or by a decrease of the presynaptic release probability at each individual synapse. To assess possible changes in the number of GABAergic synapses, we performed immunofluorescent stainings of CTZ-pretreated and control neurons with GAD, a widely used marker for GABAergic synapses. The number of GAD-immunoreactive puncta of CTZ-pretreated neurons (29.6 ± 2.1 per 100 µm dendrite, n = 14 cells) was indistinguishable from that of controls (26.9 ± 1.7, n = 14; P > 0.3) (Fig. 3A–C). Similarly punctate immunoreactivity for the general presynaptic marker SV2 was unchanged in CTZ-pretreated neurons (42.7 ± 3.2; n = 11) compared to controls (40.8 ± 3.0; n = 13; P > 0.6). These experiments suggest that the number of GABAergic and glutamatergic synapses remained unchanged in CTZ-pretreated neurons. Therefore, the reduction in the frequency of mIPSCs of CTZ-pretreated neurons is probably due to a decrease in the GABA release probability. Our results are consistent with previous findings showing that the quantal release of GABA was reduced in the hippocampal CA1 region of a rodent TLE model (Hirsch et al. 1999).
|
The unchanged amplitude of mIPSCs recorded from CTZ-pretreated neurons suggests that postsynaptic GABAA receptors remain unaffected by CTZ stimulation. To directly assess the expression of postsynaptic GABAA receptors, we used immunofluorescent staining of CTZ-treated and control neurons with an antiserum directed against the 2 subunit (Fig. 4A and B). Punctate immunofluorescence of the 2 subunit in cultured neurons and in vivo is representative of the large majority of GABAA receptors that are clustered in the postsynaptic specialization of GABAergic synapses (Essrich et al. 1998; Brunig et al. 2002; Alldred et al. 2005). Quantitative analysis of digitized fluorescence images revealed that neither the number nor the size of 2 subunit immunoreactive puncta was changed after chronic CTZ treatment (Fig. 4C and D). The number of postsynaptic 2 puncta in the control group was 26.8 ± 0.8 per 100 µm dendritic length (n
= 36) and 27.4 ± 0.7 following CTZ treatment (n
= 36; P > 0.5), consistent with the GAD staining result and confirming that the number of GABAergic synapses did not change after CTZ treatment. We also quantified the size of postsynaptic 2 puncta and found no significant alteration after CTZ treatment (control, 0.35 ± 0.02 µm2 punctum–1, n
= 36; and 0.37 ± 0.02 µm2 punctum–1 after CTZ treatment, n
= 36; P > 0.5). Thus, the expression and function of postsynaptic GABAA receptors are not affected by chronic epileptogenic stimulation of hippocampal neurons with CTZ.
|
To further study GABAA receptor functional changes after chronic CTZ treatment, we examined whole-cell GABA currents mediated by all GABAA receptors expressed on the cell surface. Rapid bath application of GABA (20 µM) was used to activate both synaptic and extrasynaptic GABAA receptors. GABA-induced whole-cell currents of CTZ-pretreated neurons showed an overt decrease in the peak amplitude compared to controls (Fig. 5A). To normalize whole-cell currents for differences in cell size, we compared the GABAA receptor current density (peak amplitude divided by cell capacitance) of CTZ-pretreated and control neurons. Interestingly, the current density of CTZ-pretreated neurons (49.3 ± 6.0 pA pF–1, n = 23) was dramatically reduced compared to the controls (81.1 ± 9.4 pA pF–1, n = 22, P < 0.01) (Fig. 5B). Importantly, we have verified that the cell size did not change significantly after CTZ or KA pretreatment. The mean cell capacitance in control cells was 40.3 ± 2.3 pF (n = 31), 38.7 ± 2.9 pF after CTZ pretreatment (n = 23, P > 0.67), and 38.3 ± 2.9 pF after KA pretreatment (n = 17, P > 0.58). Our results are consistent with previous reports that GABA-evoked whole-cell currents significantly decreased in a low-Mg2+-induced epilepsy model (Gibbs et al. 1997b).
|
Given that the number of GABAergic synapses and the postsynaptic GABAA receptors were unaltered in CTZ-pretreated neurons, a significant change in whole-cell GABA currents might reflect changes in extrasynaptic GABAA receptors. In order to test this idea, we investigated changes of tonic GABA currents, which are thought to be mediated primarily by high-affinity extrasynaptic GABAA receptors (Bai et al. 2001; Caraiscos et al. 2004; Semyanov et al. 2004). Tonic GABA currents were revealed by acute application of the GABAA receptor blocker BIC (20 µM), in the continuous presence of TTX (0.5 µM), CNQX (20 µM), and AP5 (40 µM), as previously described (Bai et al. 2001; Caraiscos et al. 2004). BIC treatment of control neurons revealed a constant outward current of approximately 20 pA (Fig. 6A). In addition to the block of mIPSCs, the baseline noise was also greatly reduced in the presence of BIC, indicating the blockade of a tonic GABA conductance. In CTZ-pretreated neurons, the tonic GABA current was greatly reduced (Fig. 6B). The all data point histograms to the right side of the current traces in Fig. 6A and B show an accurate measurement of the BIC-induced baseline shift (Caraiscos et al. 2004). The average amplitude of tonic GABA currents in CTZ-pretreated neurons (12.5 ± 1.5 pA, n = 17) was significantly reduced compared to that of control neurons (29.7 ± 4.4 pA, n = 21, P < 0.001) (Fig. 6C), suggesting that extrasynaptic GABAA receptors are downregulated after chronic CTZ-stimulation.
|
|
Because CTZ is a novel epileptogenic agent (Qi et al. 2006), the question arises whether downregulation of extrasynaptic GABAA receptors observed with CTZ could be applied to other epilepsy models as well. To address this question, we investigated the effect of chronic KA treatment on GABAergic transmission in hippocampal cultures. Chronic KA treatment (5 µM for 48 h) of hippocampal cultures induces robust epileptiform activity similar to CTZ pretreatment (Qi et al. 2006). We found that KA pretreatment significantly decreased the mIPSC frequency compared to controls (control, 2.3 ± 0.4 Hz, n = 17; KA-treated, 0.99 ± 0.18 Hz, n = 15; P < 0.005), but left the mIPSC amplitude unchanged (25.0 ± 1.3 pA in control; 21.4 ± 1.6 pA following KA treatment; P > 0.09) (Fig. 8). Thus, chronic pretreatment with KA replicates the effect on mIPSCs seen with chronic CTZ stimulation (Fig. 2). Next, we investigated the effect of chronic KA stimulation on whole-cell GABA currents. Similar to the result of CTZ-stimulation (Fig. 5), chronic KA treatment induced a significant decrease in the whole-cell response to bath-applied GABA (20 µM) (Fig. 9A). The average GABA-evoked current density was reduced from 58.3 ± 5.5 pA pF–1 in controls (n = 9) to 37.1 ± 6.8 pA pF–1 following KA pretreatment (n = 8; P < 0.03) (Fig. 9B). To further investigate changes of tonic GABA currents after KA pretreatment, we bath applied BIC (20 µM) similar to the application performed after CTZ pretreatment (Fig. 6). The tonic current in control condition was 15.2 ± 1.9 pA (n = 11), and significantly decreased after KA pretreatment (6.0 ± 0.98 pA, n = 15; P < 0.001) (Fig. 9C and D). In summary, KA pretreatment mimics the effects seen with CTZ and suggests that downregulation of tonic GABA currents is closely associated with chronic epileptogenic stimulation of cultured neurons.
|
|
|
Discussion |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
GABA tonic inhibition and epileptiform activities
GABAergic inhibition has been found to be substantially altered in epilepsy patients (Lloyd et al. 1986; During et al. 1995; Williamson et al. 1995; Patrylo et al. 2001). Detailed analysis of animal TLE models has revealed breakdown of GABAergic inhibition at multiple levels during epileptogenesis, including loss of inhibitory interneurons, loss of GABAergic nerve terminals, reduction of GABAA receptor subunits and GABA responses, and decrease of GABA release (Gibbs et al. 1997a; Brooks-Kayal et al. 1998; Hirsch et al. 1999; Kobayashi & Buckmaster, 2003; Kobayashi et al. 2003; Leroy et al. 2004; Macdonald et al. 2004; Dzhala et al. 2005; Mody, 2005). In dentate gyrus, GABAergic inhibition was also found to be increased in animal TLE models, suggesting a complexity of changes of the GABAergic system during epileptogenesis (Buhl et al. 1996; Nusser et al. 1998a; Andre et al. 2001; Sperk et al. 2004). Tonic GABA inhibition was more recently identified in cerebellar granule cells and hippocampal neurons (Kaneda et al. 1995; Brickley et al. 1996; Bai et al. 2001; Nusser & Mody, 2002). Compared to fast GABAergic synaptic transmission, the physiological significance of tonic inhibition is much less understood. Whether tonic inhibition plays a role during epileptogenesis is not well understood. Recent studies suggest that tonic GABA inhibition may play a critical function in regulating neuronal excitability in the central nervous system. A slight reduction of tonic GABA currents may result in significant increase in neuronal activity (Mitchell & Silver, 2003; Semyanov et al. 2003). The present study revealed a dramatic reduction of tonic GABA currents in association with epileptiform activity in cultured hippocampal neurons (Figs 6 and 7). Our results suggest that a minimal level of tonic inhibition may be essential for the maintenance of homeostasis of neural networks. A drastic change of tonic inhibition may drive the neural network toward a pathological status such as the induction of epileptiform activity. This conclusion is supported by recent findings that the immunolabelling of GABAA receptor 5 and subunits is significantly reduced in the hippocampus of animal TLE models (Houser & Esclapez, 2003; Peng et al. 2004). Mutations in the subunit of GABAA receptors have also been mapped in human epilepsy patients (Dibbens et al. 2004). Because GABAA receptors assembled from 5 or subunits are probably localized at extrasynaptic sites (Nusser et al. 1998b; Brunig et al. 2002; Crestani et al. 2002; Hamann et al. 2002; Wei et al. 2003), these studies imply that tonic inhibition might be depressed in animal TLE models. Interestingly, like the complexity of changes in GABAergic synaptic inhibition, the tonic inhibition may also be compensated in animal TLE models (Scimemi et al. 2005).
Regulation of synaptic versus extrasynaptic GABAA receptors after epileptogenic stimulation
One of the major findings of this study is the revealing of a preferential regulation of extrasynaptic GABAA receptors after chronic epileptogenic stimulation. In contrast, synaptically localized GABAA receptors are relatively stable (Figs 2 and 4). The preserved synaptic GABAA receptors under epileptogenic stimulation will maintain fast GABAergic transmission during the initial period of epileptogenesis.
Classical epilepsy research has been centred on GABAergic synaptic alterations (Mathern et al. 1995; Longo & Mello, 1997; Buckmaster & Jongen-Relo, 1999; Williamson et al. 1999; Magloczky et al. 2000; Kobayashi et al. 2003). The relationship between synaptic versus extrasynaptic GABAergic regulation during epileptogenesis is largely unknown. One possibility is that the synaptic and extrasynaptic GABAA receptor modulation occurs in different time windows after epileptogenic stimulation. It was found that in dentate granule cells, GABAergic inhibition decreased in 3–7 days after pilocarpine-induced status epilepticus (Kobayashi & Buckmaster, 2003), but increased after 30–45 days in fully kindled epileptic rats (Nusser et al. 1998a). The extrasynaptic GABAA receptor regulation described in the current study occurred within 48 h, whereas many previous studies on synaptic changes of GABAergic inhibition are conducted weeks or months after epileptogenic insult in animal epilepsy models (Nusser et al. 1998a; Buckmaster & Jongen-Relo, 1999; Kobayashi et al. 2003; Sperk et al. 2004). Another possibility is that changes in GABAergic inhibition may be cell type-specific after epileptogenic stimulation. For example, it has been demonstrated that the whole-cell GABAA receptor currents decreased in CA1 pyramidal neurons but increased in dentate gyrus granule cells (Gibbs et al. 1997a).
It is important to point out that our results were obtained in hippocampal cultures and after 48 h chronic epileptogenic stimulation. These in vitro studies may not mimic in vivo epileptogenesis. However, our results revealed an important link between changes of tonic GABA currents and epileptogenesis. The physiological relevance of this study is that regulation of tonic inhibition not only affects normal homeostatic neural network activity, but also may have pathological consequences.
Presynaptic GABA release and epileptogenesis
In addition to the regulation of extrasynaptic GABAA receptors, our data also show a consistent decrease of mIPSC frequency in hippocampal pyramidal neurons after KA and CTZ stimulation, indicating a significant decrease of presynaptic GABA neurotransmitter release. The amplitude of mIPSCs did not change significantly in our hippocampal culture model. These data seem to largely agree with previous reports using experimental epilepsy models. For example, in a pilocarpine-induced TLE model, mIPSC frequency and amplitude did not change in entorhinal cortical neurons (Kobayashi et al. 2003). However, the mIPSC frequency significantly reduced (64%) while the mIPSC amplitude slightly increased in dental granule cells (Kobayashi & Buckmaster, 2003). In a separate study with pilocarpine- and KA-induced TLE models, the frequency of mIPSCs recorded from CA1 pyramidal cells greatly reduced (62%), while the amplitude only slightly decreased (12%) (Hirsch et al. 1999). Thus, an emerging common feature arises from these studies that the mIPSC frequency appears to be significantly reduced to half of the control, while the amplitude of mIPSCs either does not change or shows a slight increase or decrease. Together with our findings in CTZ- and KA-treated hippocampal cultures, we propose that the substantial decrease of presynaptic GABA neurotransmitter release is one of the key contributing factors during epileptogenesis.
|
References |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
Andre V, Marescaux C, Nehlig A & Fritschy JM (2001). Alterations of hippocampal GABAergic system contribute to development of spontaneous recurrent seizures in the rat lithium-pilocarpine model of temporal lobe epilepsy. Hippocampus 11, 452–468.[CrossRef][Medline]
Bai D, Zhu G, Pennefather P, Jackson MF, MacDonald JF & Orser BA (2001). Distinct functional and pharmacological properties of tonic and quantal inhibitory postsynaptic currents mediated by gamma-aminobutyric acid(A) receptors in hippocampal neurons. Mol Pharmacol 59, 814–824.
Baulac S, Huberfeld G, Gourfinkel-An I, Mitropoulou G, Beranger A, Prud'homme JF, Baulac M, Brice A, Bruzzone R & LeGuern E (2001). First genetic evidence of GABA(A) receptor dysfunction in epilepsy: a mutation in the gamma2-subunit gene. Nat Genet 28, 46–48.[CrossRef][Medline]
Bellingham MC & Walmsley B (1999). A novel presynaptic inhibitory mechanism underlies paired pulse depression at a fast central synapse. Neuron 23, 159–170.[CrossRef][Medline]
Brickley SG, Cull-Candy SG & Farrant M (1996). Development of a tonic form of synaptic inhibition in rat cerebellar granule cells resulting from persistent activation of GABAA receptors. J Physiol 497, 753–759.[Medline]
Brickley SG, Revilla V, Cull-Candy SG, Wisden W & Farrant M (2001). Adaptive regulation of neuronal excitability by a voltage-independent potassium conductance. Nature 409, 88–92.[CrossRef][Medline]
Brooks-Kayal AR, Shumate MD, Jin H, Rikhter TY & Coulter DA (1998). Selective changes in single cell GABA(A) receptor subunit expression and function in temporal lobe epilepsy. Nat Med 4, 1166–1172.[CrossRef][Medline]
Brunig I, Scotti E, Sidler C & Fritschy JM (2002). Intact sorting, targeting, and clustering of gamma-aminobutyric acid A receptor subtypes in hippocampal neurons in vitro. J Comp Neurol 443, 43–55.[CrossRef][Medline]
Buckmaster PS & Jongen-Relo AL (1999). Highly specific neuron loss preserves lateral inhibitory circuits in the dentate gyrus of kainate-induced epileptic rats. J Neurosci 19, 9519–9529.
Buhl EH, Otis TS & Mody I (1996). Zinc-induced collapse of augmented inhibition by GABA in a temporal lobe epilepsy model. Science 271, 369–373.[Abstract]
Caraiscos VB, Elliott EM, You-Ten KE, Cheng VY, Belelli D, Newell JG, Jackson MF, Lambert JJ, Rosahl TW, Wafford KA, MacDonald JF & Orser BA (2004). Tonic inhibition in mouse hippocampal CA1 pyramidal neurons is mediated by alpha5 subunit-containing gamma-aminobutyric acid type A receptors. Proc Natl Acad Sci U S A 101, 3662–3667.
Chen Y, Deng LB, Maeno-Hikichi Y, Lai MZ, Chang SH, Chen G & Zhang JF (2003). Formation of an endophilin-Ca2+ channel complex is critical for clathrin-mediated synaptic vesicle endocytosis. Cell 115, 37–48.[CrossRef][Medline]
Chen G, Harata N & Tsien RW (2004). Paired-pulse depression of unitary quantal amplitude at single hippocampal synapses. Proc Natl Acad Sci U S A 101, 1063–1068.
Cossette P, Liu L, Brisebois K, Dong H, Lortie A, Vanasse M, Saint-Hilaire JM, Carmant L, Verner A, Lu WY, Wang YT & Rouleau GA (2002). Mutation of GABRA1 in an autosomal dominant form of juvenile myoclonic epilepsy. Nat Genet 31, 184–189.[CrossRef][Medline]
Crestani F, Keist R, Fritschy JM, Benke D, Vogt K, Prut L, Bluthmann H, Mohler H & Rudolph U (2002). Trace fear conditioning involves hippocampal alpha5 GABA(A) receptors. Proc Natl Acad Sci U S A 99, 8980–8985.
Deng LB & Chen G (2003). Cyclothiazide potently inhibits gamma-aminobutyric acid type A receptors in addition to enhancing glutamate responses. Proc Natl Acad Sci U S A 100, 13025–13029.
Diamond JS & Jahr CE (1995). Asynchronous release of synaptic vesicles determines the time course of the AMPA receptor-mediated EPSC. Neuron 15, 1097–1107.[CrossRef][Medline]
Dibbens LM, Feng HJ, Richards MC, Harkin LA, Hodgson BL, Scott D, Jenkins M, Petrou S, Sutherland GR, Scheffer IE, Berkovic SF, Macdonald RL & Mulley JC (2004). GABRD encoding a protein for extra- or peri-synaptic GABAA receptors is a susceptibility locus for generalized epilepsies. Hum Mol Genet 13, 1315–1319.
Drasbek KR & Jensen K (2006). THIP, a hypnotic and antinociceptive drug, enhances an extrasynaptic GABAA receptor-mediated conductance in mouse neocortex. Cereb Cortex 16, 1134–1141.
During MJ, Ryder KM & Spencer DD (1995). Hippocampal GABA transporter function in temporal-lobe epilepsy. Nature 376, 174–177.[CrossRef][Medline]
Dzhala VI, Talos DM, Sdrulla DA, Brumback AC, Mathews GC, Benke TA, Delpire E, Jensen FE & Staley KJ (2005). NKCC1 transporter facilitates seizures in the developing brain. Nat Med 11, 1205–1213.[CrossRef][Medline]
Essrich C, Lorez M, Benson JA, Fritschy JM & Luscher B (1998). Postsynaptic clustering of major GABAA receptor subtypes requires the gamma 2 subunit and gephyrin. Nat Neurosci 1, 563–571.[CrossRef][Medline]
Fritschy JM & Mohler H (1995). GABAA-receptor heterogeneity in the adult rat brain: differential regional and cellular distribution of seven major subunits. J Comp Neurol 359, 154–194.[CrossRef][Medline]
Gibbs JW, 3rd Shumate MD & Coulter DA (1997a). Differential epilepsy-associated alterations in postsynaptic GABA(A) receptor function in dentate granule and CA1 neurons. J Neurophysiol 77, 1924–1938.
Gibbs JW 3rd, Sombati S, DeLorenzo RJ & Coulter DA (1997b). Physiological and pharmacological alterations in postsynaptic GABA (A) receptor function in a hippocampal culture model of chronic spontaneous seizures. J Neurophysiol 77, 2139–2152.
Hamann M, Rossi DJ & Attwell D (2002). Tonic and spillover inhibition of granule cells control information flow through cerebellar cortex. Neuron 33, 625–633.[CrossRef][Medline]
Harkin LA, Bowser DN, Dibbens LM, Singh R, Phillips F, Wallace RH, Richards MC, Williams DA, Mulley JC, Berkovic SF, Scheffer IE & Petrou S (2002). Truncation of the GABA(A) -receptor gamma2 subunit in a family with generalized epilepsy with febrile seizures plus. Am J Hum Genet 70, 530–536.[CrossRef][Medline]
Harvey K, Duguid IC, Alldred MJ, Beatty SE, Ward H, Keep NH, Lingenfelter SE, Pearce BR, Lundgren J, Owen MJ, Smart TG, Luscher B, Rees MI & Harvey RJ (2004). The GDP–GTP exchange factor collybistin: an essential determinant of neuronal gephyrin clustering. J Neurosci 24, 5816–5826.
Hirsch JC, Agassandian C, Merchan-Perez A, Ben-Ari Y, DeFelipe J, Esclapez M & Bernard C (1999). Deficit of quantal release of GABA in experimental models of temporal lobe epilepsy. Nat Neurosci 2, 499–500.[CrossRef][Medline]
Houser CR & Esclapez M (2003). Downregulation of the alpha5 subunit of the GABA(A) receptor in the pilocarpine model of temporal lobe epilepsy. Hippocampus 13, 633–645.[CrossRef][Medline]
Ishikawa T & Takahashi T (2001). Mechanisms underlying presynaptic facilitatory effect of cyclothiazide at the calyx of Held of juvenile rats. J Physiol 533, 423–431.
Kaneda M, Farrant M & Cull-Candy SG (1995). Whole-cell and single-channel currents activated by GABA and glycine in granule cells of the rat cerebellum. J Physiol 485, 419–435.[Medline]
Kobayashi M & Buckmaster PS (2003). Reduced inhibition of dentate granule cells in a model of temporal lobe epilepsy. J Neurosci 23, 2440–2452.
Kobayashi M, Wen X & Buckmaster PS (2003). Reduced inhibition and increased output of layer II neurons in the medial entorhinal cortex in a model of temporal lobe epilepsy. J Neurosci 23, 8471–8479.
Krogsgaard-Larsen P, Frolund B, Liljefors T & Ebert B (2004). GABA(A) agonists and partial agonists: THIP (gaboxadol) as a non-opioid analgesic and a novel type of hypnotic. Biochem Pharmacol 68, 1573–1580.[CrossRef][Medline]
Leroy C, Poisbeau P, Keller AF & Nehlig A (2004). Pharmacological plasticity of GABA(A) receptors at dentate gyrus synapses in a rat model of temporal lobe epilepsy. J Physiol 557, 473–487.
Lindquist CE, Ebert B & Birnir B (2003). Extrasynaptic GABA(A) channels activated by THIP are modulated by diazepam in CA1 pyramidal neurons in the rat brain hippocampal slice. Mol Cell Neurosci 24, 250–257.[CrossRef][Medline]
Lloyd KG, Bossi L, Morselli PL, Munari C, Rougier M & Loiseau H (1986). Alterations of GABA-mediated synaptic transmission in human epilepsy. Adv Neurol 44, 1033–1044.[Medline]
Longo BM & Mello LE (1997). Blockade of pilocarpine- or kainate-induced mossy fiber sprouting by cycloheximide does not prevent subsequent epileptogenesis in rats. Neurosci Lett 226, 163–166.[CrossRef][Medline]
Loup F, Wieser HG, Yonekawa Y, Aguzzi A & Fritschy JM (2000). Selective alterations in GABAA receptor subtypes in human temporal lobe epilepsy. J Neurosci 20, 5401–5419.
Macdonald RL, Gallagher MJ, Feng HJ & Kang J (2004). GABA(A) receptor epilepsy mutations. Biochem Pharmacol 68, 1497–1506.[CrossRef][Medline]
Magloczky Z, Wittner L, Borhegyi Z, Halasz P, Vajda J, Czirjak S & Freund TF (2000). Changes in the distribution and connectivity of interneurons in the epileptic human dentate gyrus. Neuroscience 96, 7–25.[CrossRef][Medline]
Mathern GW, Babb TL, Pretorius JK & Leite JP (1995). Reactive synaptogenesis and neuron densities for neuropeptide Y, somatostatin, and glutamate decarboxylase immunoreactivity in the epileptogenic human fascia dentata. J Neurosci 15, 3990–4004.[Abstract]
Mitchell SJ & Silver RA (2003). Shunting inhibition modulates neuronal gain during synaptic excitation. Neuron 38, 433–445.[CrossRef][Medline]
Mody I (2005). Aspects of the homeostaic plasticity of GABAA receptor-mediated inhibition. J Physiol 562, 37–46.
Mody I & Pearce RA (2004). Diversity of inhibitory neurotransmission through GABA(A) receptors. Trends Neurosci 27, 569–575.[CrossRef][Medline]
Nusser Z, Hajos N, Somogyi P & Mody I (1998a). Increased number of synaptic GABA (A) receptors underlies potentiation at hippocampal inhibitory synapses. Nature 395, 172–177.[CrossRef][Medline]
Nusser Z & Mody I (2002). Selective modulation of tonic and phasic inhibitions in dentate gyrus granule cells. J Neurophysiol 87, 2624–2628.
Nusser Z, Sieghart W & Somogyi P (1998b). Segregation of different GABAA receptors to synaptic and extrasynaptic membranes of cerebellar granule cells. J Neurosci 18, 1693–1703.
Patrylo PR, Spencer DD & Williamson A (2001). GABA uptake and heterotransport are impaired in the dentate gyrus of epileptic rats and humans with temporal lobe sclerosis. J Neurophysiol 85, 1533–1542.
Peng Z, Huang CS, Stell BM, Mody I & Houser CR (2004). Altered expression of the delta subunit of the GABAA receptor in a mouse model of temporal lobe epilepsy. J Neurosci 24, 8629–8639.
Qi J, Wang Y, Jiang M, Warren P & Chen G (2006). Cyclothiazide induces robust epileptiform activity in rat hippocampal neurons both in vitro and in vivo. J Physiol 571, 605–618.
Richerson GB (2004). Looking for GABA in all the wrong places: the relevance of extrasynaptic GABA(A) receptors to epilepsy. Epilepsy Curr 4, 239–242.[CrossRef][Medline]
Scimemi A, Semyanov A, Sperk G, Kullmann DM & Walker MC (2005). Multiple and plastic receptors mediate tonic GABAA receptor currents in the hippocampus. J Neurosci 25, 10016–10024.
Semyanov A, Walker MC & Kullmann DM (2003). GABA uptake regulates cortical excitability via cell type-specific tonic inhibition. Nat Neurosci 6, 484–490.[Medline]
Semyanov A, Walker MC, Kullmann DM & Silver RA (2004). Tonically active GABAA receptors: modulating gain and maintaining the tone. Trends Neurosci 27, 262–269.[CrossRef][Medline]
Sperk G, Furtinger S, Schwarzer C & Pirker S (2004). GABA and its receptors in epilepsy. Adv Exp Med Biol 548, 92–103.[Medline]
Stell BM, Brickley SG, Tang CY, Farrant M & Mody I (2003). Neuroactive steroids reduce neuronal excitability by selectively enhancing tonic inhibition mediated by delta subunit-containing GABAA receptors. Proc Natl Acad Sci U S A 100, 14439–14444.
Tsunashima K, Schwarzer C, Kirchmair E, Sieghart W & Sperk G (1997). GABA(A) receptor subunits in the rat hippocampus III: altered messenger RNA expression in kainic acid-induced epilepsy. Neuroscience 80, 1019–1032.[CrossRef][Medline]
Wallace RH, Marini C, Petrou S, Harkin LA, Bowser DN, Panchal RG, Williams DA, Sutherland GR, Mulley JC, Scheffer IE & Berkovic SF (2001). Mutant GABA(A) receptor gamma2-subunit in childhood absence epilepsy and febrile seizures. Nat Genet 28, 49–52.[CrossRef][Medline]
Wei W, Zhang N, Peng Z, Houser CR & Mody I (2003). Perisynaptic localization of delta subunit-containing GABA (A) receptors and their activation by GABA spillover in the mouse dentate gyrus. J Neurosci 23, 10650–10661.
Williamson A, Patrylo PR & Spencer DD (1999). Decrease in inhibition in dentate granule cells from patients with medial temporal lobe epilepsy. Ann Neurol 45, 92–99.[Medline]
Williamson A, Telfeian AE & Spencer DD (1995). Prolonged GABA responses in dentate granule cells in slices isolated from patients with temporal lobe sclerosis. J Neurophysiol 74, 378–387.
|
Acknowledgements |
|---|
This article has been cited by other articles:
|
|
 |
|
  E. Palma, C. Roseti, F. Maiolino, S. Fucile, K. Martinello, M. Mazzuferi, E. Aronica, M. Manfredi, V. Esposito, G. Cantore, et al. GABAA-current rundown of temporal lobe epilepsy is associated with repetitive activation of GABAA "phasic" receptors PNAS, December 26, 2007; 104(52): 20944 - 20948. [Abstract] [Full Text] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
